AIM: MET1

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Representative image showing large-scale iron ore mining operations, reflecting investor focus on Rio Tinto plc’s capital intensity, iron ore margins, and balance-sheet pressures following its 2025 results and share price decline.

Fortescue (ASX: FMG) shares fall as $525m Iron Bridge impairment overshadows record shipments

CBIZ to be taken private by Grant Thornton in largest US accounting M&A in 25+ years

Saudi Arabia unveils 14-country maritime coalition to protect Red Sea shipping

WSP Global’s second Arcadis approach fails on price and paper currency concerns

Representative image of uranium mining operations, reflecting Paladin Energy’s global growth strategy and exploration focus across Namibia and Canada.

AIM: MET1 — Can Metals One’s uranium waste deal with DISA Technologies revive the stock in 2026?

Metals One Plc signs a binding uranium remediation deal with DISA Technologies. Find out how AIM: MET1 could unlock revenue from legacy waste in 2026.

μFR system
αvβ6-integrin
α4β7 integrin
Zywie Ventures
ZYUS Life Sciences
Zyrtec
Zyprexa Zydis
Zynyz
Zynga
Zynext Ventures USA LLC

October 24, 2025